gene64gu6ui :
Calling inflated U.S. chargemaster rates and private insurer overhead "full cost" ignores that Americans pay double per capita compared to other developed nations for equivalent care. It is not baseline cost; it is administrative bloat and monopoly pricing. Instead of fair pricing, we fund hundreds of thousands of administrators whose primary job is finding billing codes that charge $100 for a single aspirin, $800 in facility fees just to hand a newborn to the mother, and hundreds of millions in lobbying to keep the grift legal.
And let's not forget the blatant conflict of interest where mega-insurers now own the PBMs, the specialty pharmacies, and even manufacturing subsidiaries, routinely sidelining cheaper generics to protect their rebate kickbacks.
No, "full price" is nothing more than corporate extraction and complicit apologists stomping on the gas to protect inflated equity. Executives borrow against their shares with tax-free loans, meaning any dip risks a margin call. The more they leverage, the more desperate they are to pump the stock price. The only way to sustain that game is demanding perpetual, exponential growth on basic human survival, which is by all financial and mathematical logic completely impossible. "Full cost" is just the price tag of protecting their monopoly.
TLDR: You could order your medication straight from an overseas pharmacy, pay an individual to personally fly it first class to your front door, and it would still often be cheaper than what your U.S. insurance conglomerate demands.
2026-10-27 23:47:01